Lisa Gray

Lisa Gray was appointed to the HealthTree Foundation Board of Directors on July 10, 2026, bringing nearly 30 years of experience as an accomplished fundraising strategist and nonprofit leader. Throughout her career, she has led transformational development initiatives and teams that strengthened mission-driven organizations and expanded their capacity to deliver patient care and drive scientific discovery. Her leadership has been marked by innovative strategies to diversify and strengthen fundraising programs and foster a vibrant culture of philanthropy that accelerates mission delivery and sustainable revenue growth.

Lisa served as Senior Vice President for Development at the Pancreatic Cancer Action Network, where she led the development program and staff generating $20M+ annually. Prior to that, she held a senior vice president role at Blood Cancer United (formerly the Leukemia & Lymphoma Society), helping to drive revenue growth and deepen philanthropic support. Her LinkedIn profile indicates education from the University of Puget Sound, and her professional expertise spans major gifts, principal gifts, legacy giving, annual giving, special events, board development, and nonprofit management.

Diagnosed with multiple myeloma in 2023, Lisa has since dedicated time to supporting fellow patients and advancing research that improves outcomes across the myeloma community. Her dual perspective as both a seasoned philanthropic leader and a patient brings valuable insight to HealthTree's mission.

Career history

• Senior Vice President for Development, Pancreatic Cancer Action Network (led development program generating $20M+ annually)
• Senior Vice President, Blood Cancer United (formerly The Leukemia & Lymphoma Society)
• Board of Directors, HealthTree Foundation (appointed July 2026)

What Lisa Gray could bring to the HealthTree Foundation Board: Gray's three-decade track record building and managing high-performing development teams at leading cancer nonprofits positions her to strengthen HealthTree's fundraising strategy and philanthropic partnerships. Her experience generating $20M+ annually in development revenue and expertise in major gifts, planned giving, and corporate philanthropy could accelerate HealthTree's capacity to fund research and expand patient services. Critically, her recent diagnosis with multiple myeloma aligns her personal health advocacy with HealthTree's core mission, enabling her to authentically represent patient perspectives in board governance and strategic planning for cancer research acceleration.